PAthwAy of Dyspneic patIent in Emergency in France (Fr-PArADIse)

July 18, 2024 updated by: Pr. Nicolas GIRERD
This observational retrospective multi-center study focuses on patients treated for acute dyspnea by emergency medical teams. The primary objective is to identify factors associated with the risk of mortality and rehospitalization in these patients. This evaluation will be conducted both overall and within specific subgroups of interest, including gender (men/women), age categories, mode of admission, and comorbidities.

Study Overview

Status

Not yet recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

89700

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Besançon, France
        • CHU de Besancon
        • Contact:
          • Omide TAHERI
        • Principal Investigator:
          • Omide TAHERI, MD
        • Principal Investigator:
          • Johan COSSUS, MD
      • Dijon, France
        • CHU de DIJON
        • Contact:
          • Patrick RAY, MD, PhD
        • Principal Investigator:
          • Patrick RAY, MD, PhD
      • Lyon, France
        • Hospices civils de Lyon, Groupement Hospitalier Édouard-Herriot
        • Principal Investigator:
          • Karim TAZAROURTE, MD, PhD
        • Contact:
          • Stephanie BOSNE, MD
        • Principal Investigator:
          • Stéphanie BOSNE, MD
      • Nancy, France
        • CHRU of Nancy
        • Principal Investigator:
          • Nicolas GIRERD, MD, PhD
        • Contact:
        • Contact:
        • Principal Investigator:
          • Tahar CHOUIHED, MD, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adult patients treated in the emergency department for acute dyspnea.

Description

Inclusion Criteria:

  • Man or women aged 18 years and older.
  • Patients with acute dyspnea managed by a medical emergency team at the investigator centers between 2010 and 2021.

Exclusion Criteria:

- Cardiorespiratory arrest before emergency department management.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
All-cause post-hospitalization mortality and rehospitalization
Time Frame: Within 5 years following hospital discharge
Composite endpoint of all-cause post-hospitalization mortality and rehospitalization
Within 5 years following hospital discharge

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of readmissions (all-cause and specific - including hospitalization for acute dyspnea ).
Time Frame: 1 month and 1 year post admission for acute dyspnea in the emergency department
1 month and 1 year post admission for acute dyspnea in the emergency department
Post admission mortality
Time Frame: Within 20 years following hospital discharge
Assessed by: Composite criterion of rehospitalization and/or death following emergency department admission (short and long-term). with outcome 5.
Within 20 years following hospital discharge
Post admission rehospitalization
Time Frame: Within 20 years following hospital discharge
Assessed by: Composite criterion of rehospitalization and/or death following emergency department admission (short and long-term) with outcome with outcome 4.
Within 20 years following hospital discharge
Erroneous etiological diagnosis of dyspnea in the emergency department
Time Frame: Within hospital stay, maximum 21 days
Assessed by: defined as a discrepancy between the diagnosis at discharge from the emergency department and the final diagnosis in the hospital discharge letter
Within hospital stay, maximum 21 days
All-cause mortality and specific mortality (cardiovascular and non-cardiovascular).
Time Frame: Within 5 years following hospital discharge
Assessed by: Composite endpoint of all-cause mortality and specific mortality (cardiovascular and non-cardiovascular) with outcome 8
Within 5 years following hospital discharge
Emergency post-admission mortality
Time Frame: Within 20 years following hospital discharge
Assessed by: Composite criterion of mortality and rehospitalization post-admission for acute dyspnea in the emergency department over the long term with outcome 9
Within 20 years following hospital discharge
Emergency post-admission rehospitalisation
Time Frame: Within 20 years following hospital discharge
Assessed by: Composite criterion of mortality and rehospitalization post-admission for acute dyspnea in the emergency department over the long term outcome 8
Within 20 years following hospital discharge
Duration of stay in the emergency department
Time Frame: Within hospital stay, maximum 21 days
Assessed by: Duration of stay in the emergency department
Within hospital stay, maximum 21 days
Erroneous etiological diagnosis of dyspnea in the emergency department
Time Frame: Within hospital stay, maximum 21 days
Assessed by: Erroneous etiological diagnosis of dyspnea in the emergency department
Within hospital stay, maximum 21 days
In-hospital mortality
Time Frame: Within hospital stay, maximum 21 days
Assessed by: In-hospital mortality
Within hospital stay, maximum 21 days
Length of hospital stay
Time Frame: Within hospital stay, maximum 21 days
Assessed by: Length of hospital stay
Within hospital stay, maximum 21 days
Post emergency admission (For dyspnea) mortality and rehospitalization
Time Frame: Within 5 years following hospital discharge
Assessed by: Post emergency admission (For dyspnea) mortality and rehospitalization
Within 5 years following hospital discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tahar CHOUIHED, MD, PhD, Central Hospital, Nancy, France
  • Principal Investigator: Nicolas GIRERD, MD, PhD, CHRU de NANCY

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 30, 2024

Primary Completion (Estimated)

September 30, 2025

Study Completion (Estimated)

September 30, 2031

Study Registration Dates

First Submitted

July 4, 2024

First Submitted That Met QC Criteria

July 18, 2024

First Posted (Actual)

July 19, 2024

Study Record Updates

Last Update Posted (Actual)

July 22, 2024

Last Update Submitted That Met QC Criteria

July 18, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2022PI21

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Dyspnea

Subscribe